1. Home
  2. IBEX vs AVTX Comparison

IBEX vs AVTX Comparison

Compare IBEX & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IBEX Limited

IBEX

IBEX Limited

HOLD

Current Price

$32.47

Market Cap

376.6M

Sector

Technology

ML Signal

HOLD

Logo Avalo Therapeutics Inc.

AVTX

Avalo Therapeutics Inc.

HOLD

Current Price

$20.02

Market Cap

328.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IBEX
AVTX
Founded
2017
2011
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
376.6M
328.4M
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
IBEX
AVTX
Price
$32.47
$20.02
Analyst Decision
Hold
Strong Buy
Analyst Count
2
8
Target Price
$35.00
$40.57
AVG Volume (30 Days)
100.5K
1.8M
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
28.26
72.07
EPS
2.54
N/A
Revenue
$558,273,000.00
$27,813,137.00
Revenue This Year
$14.13
N/A
Revenue Next Year
$5.68
N/A
P/E Ratio
$12.85
N/A
Revenue Growth
9.77
2312.27
52 Week Low
$25.94
$3.39
52 Week High
$42.99
$24.27

Technical Indicators

Market Signals
Indicator
IBEX
AVTX
Relative Strength Index (RSI) 70.66 64.19
Support Level $27.56 $13.47
Resistance Level $39.65 N/A
Average True Range (ATR) 1.21 1.85
MACD 0.56 0.90
Stochastic Oscillator 82.61 63.56

Price Performance

Historical Comparison
IBEX
AVTX

About IBEX IBEX Limited

IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.

Share on Social Networks: